754
Views
68
CrossRef citations to date
0
Altmetric
PCOS

Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women

, &
Pages 275-280 | Received 30 Apr 2009, Accepted 23 Sep 2009, Published online: 09 Nov 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (16)

Ara Unanyan, Laura Pivazyan, Ekaterina Krylova, Andrey Eskin, Araksya Zakaryan, Antonina Sarkisova & Anatoly Ishchenko. (2022) Effectiveness of inositol, metformin and their combination in women with PCOS undergoing assisted reproduction: systematic review and meta-analysis. Gynecological Endocrinology 38:12, pages 1035-1046.
Read now
Zahra Bashiri, Nadia Sheibak, Fatemehsadat Amjadi & Zahra Zandieh. (2022) The role of myo-inositol supplement in assisted reproductive techniques. Human Fertility 0:0, pages 1-17.
Read now
Mariano Bizzarri, Patrizia Logoteta, Giovanni Monastra & Antonio Simone Laganà. (2022) An innovative approach to polycystic ovary syndrome. Journal of Obstetrics and Gynaecology 42:4, pages 546-556.
Read now
Fabio Facchinetti, Marialuisa Appetecchia, Cesare Aragona, Arturo Bevilacqua, Maria Salome Bezerra Espinola, Mariano Bizzarri, Rosario D’Anna, Didier Dewailly, Evanthia Diamanti-Kandarakis, Imelda Hernández Marín, Zdravko A. Kamenov, Eleni Kandaraki, Antonio Simone Laganà, Giovanni Monastra, Mario Montanino Oliva, John E. Nestler, Francesco Orio, Ali Cenk Ozay, Olga Papalou, Lali Pkhaladze, Giusy Porcaro, Nikos Prapas, Christophe O. Soulage, Annarita Stringaro, Artur Wdowiak & Vittorio Unfer. (2020) Experts’ opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond. Expert Opinion on Drug Metabolism & Toxicology 16:3, pages 255-274.
Read now
Kamal Advani, Madhulika Batra, Sangeeta Tajpuriya, Rajani Gupta, Alka Saraswat, Hemant D. Nagar, Laljee Makwana, Sarika Kshirsagar, Pushpa Kaul, Asim Kumar Ghosh, Sandhya Pradhan, Ami Mehta, Anil Jaiswal, Kartik T. Nakhate & Sandesh Kamdi. (2020) Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study. Journal of Obstetrics and Gynaecology 40:1, pages 96-101.
Read now
Anisha Agrawal, Reeta Mahey, Garima Kachhawa, Rajesh Khadgawat, Perumal Vanamail & Alka Kriplani. (2019) Comparison of metformin plus myoinositol vs metformin alone in PCOS women undergoing ovulation induction cycles: randomized controlled trial. Gynecological Endocrinology 35:6, pages 511-514.
Read now
Fabio Facchinetti, Beatrice Orrù, Giovanni Grandi & Vittorio Unfer. (2019) Short-term effects of metformin and myo-inositol in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials. Gynecological Endocrinology 35:3, pages 198-206.
Read now
Antoaneta Gateva, Vittorio Unfer & Zdravko Kamenov. (2018) The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review. Gynecological Endocrinology 34:7, pages 545-550.
Read now
Özlen Emekçi Özay, Ali Cenk Özay, Erkan Çağlıyan, Recep Emre Okyay & Bülent Gülekli. (2017) Myo-inositol administration positively effects ovulation induction and intrauterine insemination in patients with polycystic ovary syndrome: a prospective, controlled, randomized trial. Gynecological Endocrinology 33:7, pages 524-528.
Read now
Giovanni Monastra, Vittorio Unfer, Abdel Halim Harrath & Mariano Bizzarri. (2017) Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients. Gynecological Endocrinology 33:1, pages 1-9.
Read now
Cristiana Paul, Antonio Simone Laganà, Paolo Maniglio, Onofrio Triolo & David M. Brady. (2016) Inositol’s and other nutraceuticals’ synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives. Gynecological Endocrinology 32:6, pages 431-438.
Read now
Morena Luigia Rocca, Roberta Venturella, Rita Mocciaro, Annalisa Di Cello, Angela Sacchinelli, Valentina Russo, Simona Trapasso, Fulvio Zullo & Michele Morelli. (2015) Polycystic ovary syndrome: chemical pharmacotherapy. Expert Opinion on Pharmacotherapy 16:9, pages 1369-1393.
Read now
Zdravko Kamenov, Georgi Kolarov, Antoaneta Gateva, Gianfranco Carlomagno & Alessandro D. Genazzani. (2015) Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. Gynecological Endocrinology 31:2, pages 131-135.
Read now
Vittorio Unfer & Giuseppina Porcaro. (2014) Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome. Expert Review of Clinical Pharmacology 7:5, pages 623-631.
Read now
V. Unfer, G. Carlomagno, G. Dante & F. Facchinetti. (2012) Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecological Endocrinology 28:7, pages 509-515.
Read now
Paolo Giovanni Artini, Francesca Papini, Maria Ruggiero, Giulia Scaravelli, Olga Maria Di Berardino, Giovanna Simi & Vito Cela. (2011) Difficult-to-treat women for controlled ovarian hyperstimulation: tips and tricks. Expert Review of Endocrinology & Metabolism 6:4, pages 617-627.
Read now

Articles from other publishers (52)

Kaneez Fatima, Zainab Jamil, Samar Faheem, Alishba Adnan, Syed Sarmad Javaid, Hafsa Naeem, Neha Mohiuddin, Anosha Sajid & Sidhant Ochani. (2023) Effects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysis. Irish Journal of Medical Science (1971 -) 192:6, pages 2801-2808.
Crossref
Zdravko Kamenov, Antoaneta Gateva, Simona Dinicola & Vittorio Unfer. (2023) Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome. Metabolites 13:6, pages 717.
Crossref
Gabriella Guarnieri, Matteo Iervolino, Sara Cavallone, Vittorio Unfer & Andrea Vianello. (2023) The “Asthma-Polycystic Ovary Overlap Syndrome” and the Therapeutic Role of Myo-Inositol. International Journal of Molecular Sciences 24:8, pages 6959.
Crossref
Carmen Concerto, Cecilia Chiarenza, Antonio Di Francesco, Antimo Natale, Ivan Privitera, Alessandro Rodolico, Antonio Trovato, Andrea Aguglia, Francesco Fisicaro, Manuela Pennisi, Rita Bella, Antonino Petralia, Maria Salvina Signorelli & Giuseppe Lanza. (2023) Neurobiology and Applications of Inositol in Psychiatry: A Narrative Review. Current Issues in Molecular Biology 45:2, pages 1762-1778.
Crossref
Dorina Greff, Anna E. Juhász, Szilárd Váncsa, Alex Váradi, Zoltán Sipos, Julia Szinte, Sunjune Park, Péter Hegyi, Péter Nyirády, Nándor Ács, Szabolcs Várbíró & Eszter M. Horváth. (2023) Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reproductive Biology and Endocrinology 21:1.
Crossref
Zdravko Kamenov & Mario Montanino Oliva. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols 65 72 .
M. S. Titova, M. I. Kolodina, A. S. Lyashenko & E. N. Lyashenko. (2022) Use of myo-inositol in women with polycystic ovary syndrome in the application of auxiliary reproductive technologies. Meditsinskiy sovet = Medical Council:16, pages 50-56.
Crossref
Hardik Jethaliya, Nirva Gajjar, Vrushank Patel, Shrikalp Deshpande & Roshni Patel. (2022) Efficacy of Myo-inositol on Anthropometric, Metabolic, and Endocrine Outcomes in PCOS Patients: a Meta-analysis of Randomized Controlled Trial. Reproductive Sciences 29:8, pages 2282-2298.
Crossref
Garima Kachhawa, Krithika V. Senthil Kumar, Vidushi Kulshrestha, Rajesh Khadgawat, Reeta Mahey & Neerja Bhatla. (2021) Efficacy of myo‐inositol and d ‐chiro‐inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: A randomized open‐label study . International Journal of Gynecology & Obstetrics 158:2, pages 278-284.
Crossref
Reem Magzoub, Elrasheid A.H. Kheirelseid, Claire Perks & Sarah Lewis. (2022) Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology 271, pages 38-62.
Crossref
Philippe Merviel, Pandora James, Sarah Bouée, Mathilde Le Guillou, Camille Rince, Charlotte Nachtergaele & Véronique Kerlan. (2021) Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies. Reproductive Health 18:1.
Crossref
Selma FIRAT & Mehmet FİSUNOĞLU. (2021) Polikistik Over Sendromunda Güncel Terapötik Ajanlardan İnositol ve Alfa Lipoik Asit Takviyesi Üzerine Bir Derleme. Akdeniz Medical Journal 7:2, pages 184-196.
Crossref
Anupama Bahadur, Hitanshi Arora, Anoosha K Ravi, Manisha Naithani, Yogesh Bahurupi, Jaya Chaturvedi, Megha Ajmani & Rajlaxmi Mundhra. (2021) Comparison of Clinical, Metabolic and Hormonal Effects of Metformin Versus Combined Therapy of Metformin With Myoinositol Plus D-Chiro-Inositol in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial. Cureus.
Crossref
Riccardo Gambioli, Gianpiero Forte, Giovanni Buzzaccarini, Vittorio Unfer & Antonio Simone Laganà. (2021) Myo-Inositol as a Key Supporter of Fertility and Physiological Gestation. Pharmaceuticals 14:6, pages 504.
Crossref
Yueting Deng, Chen Huang, Jingyue Su, Chen-Wei Pan & Chaofu Ke. (2021) Identification of biomarkers for essential hypertension based on metabolomics. Nutrition, Metabolism and Cardiovascular Diseases 31:2, pages 382-395.
Crossref
Aslı Yaylalı, Murat Bakacak & Zeyneb Bakacak. (2021) The efficacy of different insulin-sensitizing agents on treatment outcomes in patients with polycystic ovary syndrome who underwent in-vitro fertilization: A retrospective, record-based, comparative study. Journal of Gynecology Obstetrics and Human Reproduction 50:1, pages 102006.
Crossref
O. M. Nosenko & O. V. Novikova. (2020) Inositols in reproductive medicine. REPRODUCTIVE ENDOCRINOLOGY:56, pages 23-34.
Crossref
Zdravko Kamenov & Antoaneta Gateva. (2020) Inositols in PCOS. Molecules 25:23, pages 5566.
Crossref
Vittorio Unfer, Simona Dinicola, Antonio Simone Laganà & Mariano Bizzarri. (2020) Altered Ovarian Inositol Ratios May Account for Pathological Steroidogenesis in PCOS. International Journal of Molecular Sciences 21:19, pages 7157.
Crossref
Marian G Showell, Rebecca Mackenzie-Proctor, Vanessa Jordan & Roger J Hart. (2020) Antioxidants for female subfertility. Cochrane Database of Systematic Reviews 2020:11.
Crossref
Fabio Facchinetti, Vittorio Unfer, Didier Dewailly, Zdravko A. Kamenov, Evanthia Diamanti-Kandarakis, Antonio Simone Laganà, John E. Nestler & Christophe O. Soulage. (2020) Inositols in Polycystic Ovary Syndrome: An Overview on the Advances. Trends in Endocrinology & Metabolism 31:6, pages 435-447.
Crossref
M. Caputo, E. Bona, I. Leone, M.T. Samà, A. Nuzzo, A. Ferrero, G. Aimaretti, P. Marzullo & F. Prodam. (2020) Inositols and metabolic disorders: From farm to bedside. Journal of Traditional and Complementary Medicine 10:3, pages 252-259.
Crossref
Heidy Cabrera-Cruz, Lorena Oróstica, Francisca Plaza-Parrochia, Ignacio Torres-Pinto, Carmen Romero & Margarita Vega. (2020) The insulin-sensitizing mechanism of myo-inositol is associated with AMPK activation and GLUT-4 expression in human endometrial cells exposed to a PCOS environment. American Journal of Physiology-Endocrinology and Metabolism 318:2, pages E237-E248.
Crossref
І. А. Жабченко & О. Р. Сюдмак. (2019) Problems of delayed birth: the features of fertility in older reproductive age women and their correction methods. Reproductive Endocrinology 0:49, pages 43-49.
Crossref
Sajadeh Pourghasem, Fatemeh Bazarganipour, Seyed Abdolvahab Taghavi & Maryam Azizi Kutenaee. (2019) The effectiveness of inositol and metformin on infertile polycystic ovary syndrome women with resistant to letrozole. Archives of Gynecology and Obstetrics 299:4, pages 1193-1199.
Crossref
Gabriel Levin & Amihai Rottenstreich. (2019) Inositol for women with polycystic ovary syndrome-possibly just better than placebo. Acta Obstetricia et Gynecologica Scandinavica 98:2, pages 262-262.
Crossref
Christian Egarter. (2018) Myo-InositolMyo-inositol. Gynäkologische Endokrinologie 17:1, pages 11-15.
Crossref
Marian G Showell, Rebecca Mackenzie-Proctor, Vanessa Jordan, Ruth Hodgson & Cindy Farquhar. (2018) Inositol for subfertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2018:12.
Crossref
Dylan A. Cutler, Alana K. Shaw, Sheila M. Pride, Mohamed A. Bedaiwy & Anthony P. Cheung. (2018) A randomized controlled trial comparing lifestyle intervention to letrozole for ovulation in women with polycystic ovary syndrome: a study protocol. Trials 19:1.
Crossref
Mario Montanino Oliva, Giovanna Buonomo, Marco Calcagno & Vittorio Unfer. (2018) Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women. Journal of Ovarian Research 11:1.
Crossref
Antonio Simone Laganà, Simone Garzon, Jvan Casarin, Massimo Franchi & Fabio Ghezzi. (2018) Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach. Trends in Endocrinology & Metabolism 29:11, pages 768-780.
Crossref
Pedro-Antonio Regidor, Adolf Eduard Schindler, Bernd Lesoine & Rene Druckman. (2018) Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature. Hormone Molecular Biology and Clinical Investigation 34:2.
Crossref
J Pundir, D Psaroudakis, P Savnur, P Bhide, L Sabatini, H Teede, A Coomarasamy & S Thangaratinam. (2018) Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials. BJOG: An International Journal of Obstetrics & Gynaecology 125:3, pages 299-308.
Crossref
T. A. Nazarenko & K. M. Isakova. (2018) Influence of Inositol on the reproductive system of infertile patients, quality of gametes and embryos (a review). Problemy reproduktsii 24:4, pages 33.
Crossref
John E. Nestler & Antonio Simone Laganà. 2018. Infertility in Women with Polycystic Ovary Syndrome. Infertility in Women with Polycystic Ovary Syndrome 213 226 .
R Hanna, T Wehbe & EA Jaoude. (2017) Metabolic Effects of D-Chiro-Inositol and Myo-Inositol in Polycystic Ovary Syndrome. International Journal of Clinical Endocrinology and Metabolism 3:1, pages 029-033.
Crossref
Marian G Showell, Rebecca Mackenzie-Proctor, Vanessa Jordan & Roger J Hart. (2017) Antioxidants for female subfertility. Cochrane Database of Systematic Reviews.
Crossref
Maria A. Sortino, Salvatore Salomone, Michele O. Carruba & Filippo Drago. (2017) Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols. Frontiers in Pharmacology 8.
Crossref
Valeria Tagliaferri, Daniela Romualdi, Valentina Immediata, Simona De Cicco, Christian Di Florio, Antonio Lanzone & Maurizio Guido. (2017) Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study . Clinical Endocrinology 86:5, pages 725-730.
Crossref
Esmée M Bordewijk, Marleen Nahuis, Michael F Costello, Fulco Van der Veen, Leopoldo O Tso, Ben Willem J Mol & Madelon van Wely. (2017) Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2017:1.
Crossref
Pedro-Antonio Regidor & Adolf Eduard Schindler. (2016) Myoinositol as a Safe and Alternative Approach in the Treatment of Infertile PCOS Women: A German Observational Study. International Journal of Endocrinology 2016, pages 1-5.
Crossref
Vittorio Unfer, John E. Nestler, Zdravko A. Kamenov, Nikos Prapas & Fabio Facchinetti. (2016) Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials. International Journal of Endocrinology 2016, pages 1-12.
Crossref
Francesco Corrado & Angelo Santamaria. 2015. Glucose Intake and Utilization in Pre-Diabetes and Diabetes. Glucose Intake and Utilization in Pre-Diabetes and Diabetes 229 234 .
Simona Dinicola, Tony T. Y. Chiu, Vittorio Unfer, Gianfranco Carlomagno & Mariano Bizzarri. (2014) The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome. The Journal of Clinical Pharmacology 54:10, pages 1079-1092.
Crossref
Sandra Colazingari, Mariangela Treglia, Robert Najjar & Arturo Bevilacqua. (2013) The combined therapy myo-inositol plus d-chiro-inositol, rather than d-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial. Archives of Gynecology and Obstetrics 288:6, pages 1405-1411.
Crossref
Marine L. Croze & Christophe O. Soulage. (2013) Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie 95:10, pages 1811-1827.
Crossref
Marian G Showell, Julie Brown, Jane Clarke & Roger J Hart. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Rosalbino Isabella & Emanuela Raffone. (2012) CONCERN: Does ovary need D-chiro-inositol?. Journal of Ovarian Research 5:1.
Crossref
Michelle Greiver, Babak Aliarzadeh, Rahim Moineddin, Christopher Meaney & Noah Ivers. (2011) Diabetes screening with hemoglobin A1c prior to a change in guideline recommendations: prevalence and patient characteristics. BMC Family Practice 12:1.
Crossref
Enrico Papaleo. (2011) Inositol effects on ovulation induction in patients with polycystic ovary syndrome. Fertility and Sterility 95:7, pages e47.
Crossref
Giuseppe Morgante, Raoul Orvieto, Alessandra Di Sabatino, Maria C. Musacchio & Vincenzo De Leo. (2011) The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen. Fertility and Sterility 95:8, pages 2642-2644.
Crossref
Niki Katsiki & Apostolos I Hatzitolios. (2010) Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update. Current Opinion in Obstetrics & Gynecology 22:6, pages 466-476.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.